Author:
Y. Shan Frank,Wu Huanwen,Zhong Dingrong,Ai Di,Zreik Riyam,H. Huang Jason
Abstract
Tumors of mesenchymal origin, also called soft tissue tumors, include tumor from muscle, fat, fibrous tissue, vessels and nerves, which are a group of heterogeneous neoplasms, and accounts for about 1% of all malignant tumors. They are uncommon tumors in routine practice, with complex tumorigenesis. Due to the recent advance in molecular pathology, we got a major achievement in the understanding of these tumors at the gene level, which makes the diagnosis and prognosis of this type of tumor more accurate and comfortable. This chapter will cover some molecular pathology and diagnosis of soft tissue and bone tumors.
Reference65 articles.
1. Schaefer I-M, Hornick J. Diagnostic immunohistochemistry for soft tissue and bone tumors: An update. Advances in Anatomic Pathology. 2018;25(6):400-412
2. Slominski A, Wortman J, Carlson A, Mihm M, Nickoloff B, McClatchey K. Molecular pathology of soft tissue and bone tumors, a review. Archives of Pathology Laboratory Medicine. 1999;123:1246-1259
3. Sabbioni S, Barbanti-Brodano G, Croce C. Negrini M.GOK: A geneat 11p15 involved in rhabdomyosarcoma and rhabdoid tumordevelopment. Cancer Research. 1997;57:4493-4497
4. Yamamoto H, Irie A, Fukushima Y, et al. Abrogation of lung metatstasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin alpha 6 subunit expression. International Journal of Cancer. 1996;65:519-524
5. Cordon-Cordo C. Mutation of cell cycle regulation: Biological and clinical implication for human neoplasia. American Journal of Pathology. 1995;147:545-560